Related Experiment Video
Updated: Dec 17, 2025

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects
Kyung-Hee Kim1, Eun Pyo Hong1, Jun Wan Shin1
1Molecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Neurology, Harvard Medical School, Boston, MA 02115, USA.
Genetic variations in the DNA repair gene Fanconi-Associated Nuclease 1 (FAN1) influence Huntington disease (HD) onset. These FAN1 gene modifiers affect DNA repair and CAG repeat instability, impacting therapeutic strategies for HD.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Genome-wide association studies identified DNA maintenance genes as Huntington disease (HD) onset modifiers.
- Significant signals were found in a chr15 region containing the DNA repair gene Fanconi-Associated Nuclease 1 (FAN1).
Purpose of the Study:
- To investigate genetic, molecular, and cellular mechanisms of FAN1 modifiers influencing HD onset.
- To explore how FAN1 variations impact DNA repair, CAG repeat instability, and HD progression.
Main Methods:
- Detailed genetic analysis of FAN1 locus modifiers.
- Molecular assays to assess FAN1 DNA-binding activity and cellular function.
- Investigation of FAN1 mRNA expression and knockout effects in HD-induced pluripotent stem cells.
Main Results:
- Specific FAN1 missense variants (p.Arg507His, p.Arg377Trp) reduced DNA-binding and DNA repair capacity, acting as onset-hastening modifiers.
- A frequent onset-delaying modifier correlated with increased FAN1 mRNA expression.
- FAN1 knockout exacerbated CAG repeat expansion in HD stem cells, confirming its role in repeat instability.
Conclusions:
- Multiple genetic variations acting through FAN1, via different mechanisms, additively influence HD onset.
- Somatic CAG repeat expansion is a viable therapeutic target in HD.
- FAN1 haplotype combinations may affect patient eligibility for clinical trials targeting CAG repeat instability.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genetic Lingo
Incomplete Dominance
Pleiotropy
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

